Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AR F877L
i
Other names:
AR, AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1, Androgen receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
367
Related biomarkers:
Expression
Mutation
CNA
Others
‹
AR mutation (9)
AR T878A (5)
AR splice variant 7 (5)
AR H875Y (2)
AR L702H (2)
AR wild-type (2)
AKT1 mutation + AR mutation (1)
AR D891H (1)
AR F876L (1)
AR F877L + AR T878A (1)
AR H100Q (1)
AR L329W (1)
AR T877A (1)
AR T878A + AR H875Y (1)
AR T878S (1)
AR T878S + AR H875Y (1)
AR W741C (1)
AR W741L (1)
AR splice variant 7 negative (1)
AR splice variant 9 (1)
AR mutation (9)
AR T878A (5)
AR splice variant 7 (5)
AR H875Y (2)
AR L702H (2)
AR wild-type (2)
AKT1 mutation + AR mutation (1)
AR D891H (1)
AR F876L (1)
AR F877L + AR T878A (1)
AR H100Q (1)
AR L329W (1)
AR T877A (1)
AR T878A + AR H875Y (1)
AR T878S (1)
AR T878S + AR H875Y (1)
AR W741C (1)
AR W741L (1)
AR splice variant 7 negative (1)
AR splice variant 9 (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
AR F877L
Prostate Cancer
AR F877L
Prostate Cancer
enzalutamide
Resistant: C3 – Early Trials
enzalutamide
Resistant
:
C3
enzalutamide
Resistant: C3 – Early Trials
enzalutamide
Resistant
:
C3
AR F877L
Prostate Cancer
AR F877L
Prostate Cancer
apalutamide
Resistant: C3 – Early Trials
apalutamide
Resistant
:
C3
apalutamide
Resistant: C3 – Early Trials
apalutamide
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login